H C Lin1, R C Purohit, T A Powe. 1. Department of Large Animal Surgery and Medicine, College of Veterinary Medicine, Auburn University, AL 36849-5522, USA.
Abstract
OBJECTIVE: This study evaluates the clinical usefulness and anesthetic effect of propofol, and compares these effects with those of xylazine-ketamine-halothane anesthesia in sheep. STUDY DESIGN: Prospective, randomized, clinical trial. ANIMALS OR SAMPLE POPULATION: Fourteen healthy adult male sheep. METHODS: Sheep were randomly assigned to two different drug regimens: (1) Bolus injection of propofol (3 mg/kg, intravenously [i.v.]) followed by continuous intravenous infusion and (2) xylazine (0.11 mg/kg, i.v.) and ketamine (2.2 mg/kg, i.v.) for induction followed by halothane anesthesia. Heart rate, respiratory rate, and arterial blood pressures were monitored during anesthesia. Venous blood samples were collected for blood gas analysis. Quality of induction and recovery were also recorded. RESULTS: The average dose of propofol used to induce and maintain anesthesia was 6.63 +/- 2.06 mg/kg and 29.3 +/- 11.7 mg/kg/hr (0.49 +/- 0.20 mg/kg/min), respectively. The duration of propofol anesthesia was 45.3 +/- 13.2 minutes and recovery to standing occurred in 14.7 +/- 5.7 minutes. Sheep receiving xylazine-ketamine-halothane were anesthetized for 35.9 +/- 4.0 minutes and recovery to standing occurred within 28.5 +/- 7.5 minutes. Sheep anesthetized with propofol had a significantly higher heart rate, diastolic blood pressure and Pvo2, and a lower Pvco2 at 30 minutes and lower BE at 15 and 30 minutes than sheep anesthetized with xylazine-ketamine-halothane. CONCLUSIONS: Propofol anesthesia was characterized by a smooth induction, effective surgical anesthesia and rapid recovery which was comparable to anesthesia with xylazine-ketamine-halothane. CLINICAL RELEVANCE: Propofol may be indicated in situations when it is desirable to maintain anesthesia with an intravenous infusion followed by a rapid recovery in healthy sheep.
OBJECTIVE: This study evaluates the clinical usefulness and anesthetic effect of propofol, and compares these effects with those of xylazine-ketamine-halothane anesthesia in sheep. STUDY DESIGN: Prospective, randomized, clinical trial. ANIMALS OR SAMPLE POPULATION: Fourteen healthy adult male sheep. METHODS:Sheep were randomly assigned to two different drug regimens: (1) Bolus injection of propofol (3 mg/kg, intravenously [i.v.]) followed by continuous intravenous infusion and (2) xylazine (0.11 mg/kg, i.v.) and ketamine (2.2 mg/kg, i.v.) for induction followed by halothane anesthesia. Heart rate, respiratory rate, and arterial blood pressures were monitored during anesthesia. Venous blood samples were collected for blood gas analysis. Quality of induction and recovery were also recorded. RESULTS: The average dose of propofol used to induce and maintain anesthesia was 6.63 +/- 2.06 mg/kg and 29.3 +/- 11.7 mg/kg/hr (0.49 +/- 0.20 mg/kg/min), respectively. The duration of propofol anesthesia was 45.3 +/- 13.2 minutes and recovery to standing occurred in 14.7 +/- 5.7 minutes. Sheep receiving xylazine-ketamine-halothane were anesthetized for 35.9 +/- 4.0 minutes and recovery to standing occurred within 28.5 +/- 7.5 minutes. Sheep anesthetized with propofol had a significantly higher heart rate, diastolic blood pressure and Pvo2, and a lower Pvco2 at 30 minutes and lower BE at 15 and 30 minutes than sheep anesthetized with xylazine-ketamine-halothane. CONCLUSIONS:Propofol anesthesia was characterized by a smooth induction, effective surgical anesthesia and rapid recovery which was comparable to anesthesia with xylazine-ketamine-halothane. CLINICAL RELEVANCE: Propofol may be indicated in situations when it is desirable to maintain anesthesia with an intravenous infusion followed by a rapid recovery in healthy sheep.
Authors: Hussam Al Hussein; Hamida Al Hussein; Carmen Sircuta; Ovidiu S Cotoi; Ionela Movileanu; Dan Nistor; Bogdan Cordos; Radu Deac; Horatiu Suciu; Klara Brinzaniuc; Dan T Simionescu; Marius M Harpa Journal: Tissue Eng Regen Med Date: 2020-08-29 Impact factor: 4.169
Authors: Adam J Wells; Robert Vink; Stephen C Helps; Steven J Knox; Peter C Blumbergs; Renée J Turner Journal: PLoS One Date: 2015-06-29 Impact factor: 3.240
Authors: Wonhye Lee; Stephanie D Lee; Michael Y Park; Lori Foley; Erin Purcell-Estabrook; Hyungmin Kim; Seung-Schik Yoo Journal: BMC Vet Res Date: 2015-10-14 Impact factor: 2.741
Authors: Annabel J Sorby-Adams; Anna V Leonard; Levi E Elms; Oana C Marian; Jan W Hoving; Nawaf Yassi; Robert Vink; Emma Thornton; Renée J Turner Journal: Front Neurosci Date: 2019-07-09 Impact factor: 4.677